3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
2
Status
Unknown
2
Recruiting
2
Completed
2
Sponsor Class
NETWORK
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Carcinoma, Non-Small-Cell Lung
381
Breast Neoplasms
364
Colorectal Neoplasms
238
Stomach Neoplasms
218
Carcinoma, Hepatocellular
155
Lung Neoplasms
123
Neoplasms
120
Pancreatic Neoplasms
109
Prostatic Neoplasms
100
Neoplasm Metastasis
96
Recurrence
95
Rectal Neoplasms
95
Ovarian Neoplasms
90
Nasopharyngeal Carcinoma
88
Esophageal Neoplasms
82
Esophageal Squamous Cell Carcinoma
81
Lymphoma, Large B-Cell, Diffuse
79
Melanoma
75
Small Cell Lung Carcinoma
71
Uterine Cervical Neoplasms
70
Lymphoma
70
Leukemia, Myeloid, Acute
70
Brain Neoplasms
69
Sarcoma
68
Head and Neck Neoplasms
68
Squamous Cell Carcinoma of Head and Neck
67
Multiple Myeloma
65
Carcinoma, Renal Cell
63
Triple Negative Breast Neoplasms
61
Lymphoma, Non-Hodgkin
53
Interventions
salicylhydroxamic acid
1
Medical Marijuana
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Unknown
×
Opioid-Related Disorders
×
Clear all
NCT03944447
2022-06-02
OMNI-Can
OMNI Medical Services, LLC
Phase 2
Unknown
200,000 enrolled
NCT04850664
2021-08-06
CBOT-OUD
Evon Medics LLC
Phase 2
Unknown
190 enrolled